Green, Kim N <br/><br/>
ST101 induces a novel 17 kDa APP cleavage that precludes Aβ generation in vivo.  [electronic resource] 

 -  Annals of neurology  May 2011 
 - 831-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1531-8249 
<br/><br/><label>Standard No.: </label>10.1002/ana.22325  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Amyloid beta-Protein Precursor--genetics<br/>Amyloidogenic Proteins--drug effects<br/>Animals<br/>Brain--drug effects<br/>Cathepsin D--metabolism<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Humans<br/>Indans--pharmacology<br/>Macaca fascicularis<br/>Maze Learning--drug effects<br/>Memory--drug effects<br/>Mice<br/>Mice, Transgenic<br/>Molecular Weight<br/>Neuroblastoma--pathology<br/>Peptide Fragments--metabolism<br/>Proteomics--methods<br/>Reaction Time--drug effects<br/>Schizophrenia--drug therapy<br/>Spiro Compounds--pharmacology<br/>Subcellular Fractions--drug effects<br/>Transfection<br/>Tubulin--metabolism<br/>tau Proteins--genetics